These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555 [TBL] [Abstract][Full Text] [Related]
27. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds. Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830 [TBL] [Abstract][Full Text] [Related]
28. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C; J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457 [TBL] [Abstract][Full Text] [Related]
29. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385 [TBL] [Abstract][Full Text] [Related]
30. Effect of neointimal tissue morphology on vascular response to balloon angioplasty in lesions with in-stent restenosis after drug-eluting stent deployment: an optical coherence tomography analysis. Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Shimatani Y; Hasegawa K; Ishibuchi K; Tamaru H; Ishii R; Yasuda S; Taniguchi Y; Nakabayashi S; Kusumoto H; Higashino Y Heart Vessels; 2020 Sep; 35(9):1193-1200. PubMed ID: 32253529 [TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomography and histopathological assessment of delayed arterial healing after drug-eluting stent implant in a pig coronary model. Matsumoto D; Shinke T; Nakamura T; Shite J; Li J; Hou D; Chronos N Int J Cardiol; 2013 Dec; 170(2):152-9. PubMed ID: 24157235 [TBL] [Abstract][Full Text] [Related]
32. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ; JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548 [TBL] [Abstract][Full Text] [Related]
33. In-Stent Restenosis with "Inflammatory" Neointima Following Everolimus-Eluting Stent Implantation. Tsuji Y; Koide M; Katsura K; Fujita H; Ishibashi-Ueda H; Otsuka F Int Heart J; 2018 Sep; 59(5):1142-1145. PubMed ID: 30012926 [TBL] [Abstract][Full Text] [Related]
34. Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial. Yamasaki M; Tsujino I; Lima-Filho MO; Ako J; Shimohama T; Hasegawa T; Sakurai R; Sudhir K; Stone GW; Waseda K; Honda Y; Fitzgerald PJ EuroIntervention; 2012 Oct; 8(6):724-31. PubMed ID: 23086791 [TBL] [Abstract][Full Text] [Related]
35. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. Windecker S; Haude M; Neumann FJ; Stangl K; Witzenbichler B; Slagboom T; Sabaté M; Goicolea J; Barragan P; Cook S; Piot C; Richardt G; Merkely B; Schneider H; Bilger J; Erne P; Waksman R; Zaugg S; Jüni P; Lefèvre T Circ Cardiovasc Interv; 2015 Feb; 8(2):e001441. PubMed ID: 25634905 [TBL] [Abstract][Full Text] [Related]
36. Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis. Yoneyama K; Koyama K; Tanabe Y; Mitarai T; Kamijima R; Kuwata S; Yamazaki H; Nakano E; Kongoji K; Harada T; Akashi YJ Int J Cardiol; 2014 Oct; 176(3):1207-9. PubMed ID: 25129263 [No Abstract] [Full Text] [Related]
37. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study. Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858 [TBL] [Abstract][Full Text] [Related]
38. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis. Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685 [TBL] [Abstract][Full Text] [Related]
39. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Alfonso F; Dutary J; Paulo M; Gonzalo N; Pérez-Vizcayno MJ; Jiménez-Quevedo P; Escaned J; Bañuelos C; Hernández R; Macaya C Heart; 2012 Aug; 98(16):1213-20. PubMed ID: 22826559 [TBL] [Abstract][Full Text] [Related]
40. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]